内源性大麻素与创伤后应激障碍:可能的作用机制与治疗应用
Endocannabinoid and post-traumatic stress disorder: Possible mechanisms and clinical application
查看参考文献146篇
|
文摘
|
近年来,内源性大麻素系统已被视为创伤后应激障碍(PTSD)未来药物治疗的新靶标。实证研究提示,内源性大麻素系统可能通过影响个体的恐惧记忆加工、焦虑与抑郁表型以及奖励与动机调控而参与了PTSD的发生发展。应用适量的大麻素类物质可缓解PTSD症状,尤其可以改善患者的睡眠问题。未来的研究应进一步明确内源性大麻素系统在PTSD病因学中的作用机制,提高现有药用大麻素类物质的临床安全性,并发展新型大麻素受体调节剂。另外,探讨遗传因素和反应异质性在内源性大麻素治疗PTSD中的作用,也将促进治疗人群的早期识别和精准医疗的发展。 |
|
其他语种文摘
|
Recently, endocannabinoid system has been proposed as a new pharmacological target of post-traumatic stress disorder (PTSD). Empirical studies indicated that endocannabinoid system is closely linked to the occurrence and development of PTSD due to its important roles in regulating the fear memory, anxiety, depression, reward as well as motivation. Several clinical studies also found that appropriate dose of cannabinoids can relieve PTSD symptoms, especially the sleep problems. Future studies should further explore the pathological mechanism of endocannabinoid system in PTSD, increase the clinical security of medicinal cannabinoids,and develop the new kinds of cannabinoid receptor modulators. In addition, investigating of the influence of genetic factors and heterogeneity of responses in the effect of endocannabinoid on treatment of PTSD will also promote the early identification of the patients and the development of precision medicine. |
|
来源
|
心理科学进展
,2017,25(12):2043-2056 【核心库】
|
|
DOI
|
10.3724/SP.J.1042.2017.02043
|
|
关键词
|
内源性大麻素
;
创伤后应激障碍
;
恐惧记忆
;
焦虑
;
抑郁
|
|
地址
|
中国科学院心理研究所, 中国科学院心理健康重点实验室, 北京, 100101
|
|
语种
|
中文 |
|
文献类型
|
研究性论文 |
|
ISSN
|
1671-3710 |
|
学科
|
社会科学总论 |
|
基金
|
国家自然科学基金面上项目
;
中国科学院对外合作重点项目
|
|
文献收藏号
|
CSCD:6130749
|
参考文献 共
146
共8页
|
|
1.
Admon R. A causal model of post-traumatic stress disorder: Disentangling predisposed from acquired neural abnormalities.
Trends in Cognitive Sciences,2013,17:337-347
|
被引
4
次
|
|
|
|
|
2.
Alvarez-Jaimes L. Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala.
Neuropsychopharmacology,2008,33:2483-2493
|
被引
4
次
|
|
|
|
|
3.
Armour C. Dimensional structure of DSM-5 posttraumatic stress symptoms: Support for a hybrid Anhedonia and Externalizing Behaviors model.
Journal of Psychiatric Research,2015,61:106-113
|
被引
5
次
|
|
|
|
|
4.
Atsak P. Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory.
Proceedings of the National Academy of Sciences of the United States of America,2012,109:3504-3509
|
被引
4
次
|
|
|
|
|
5.
Atsak P. Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences.
Neuroscience,2012,204:104-116
|
被引
3
次
|
|
|
|
|
6.
Azad S C. Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala.
Learning & Memory,2008,15:143-152
|
被引
1
次
|
|
|
|
|
7.
Badia-Castello M. Recall and memory after intensive care unit stay. Development of posttraumatic stress disorder.
Medicina Clinica,2006,126:561-566
|
被引
1
次
|
|
|
|
|
8.
Bergamaschi M M. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-Naive social phobia patients.
Neuropsychopharmacology,2011,36:1219-1226
|
被引
8
次
|
|
|
|
|
9.
Berghuis P. Hardwiring the brain: Endocannabinoids shape neuronal connectivity.
Science,2007,316:1212-1216
|
被引
3
次
|
|
|
|
|
10.
Betthauser K. Use and effects of cannabinoids in military veterans with posttraumatic stress disorder.
American Journal of Health-system Pharmacy,2015,72:1279-1284
|
被引
2
次
|
|
|
|
|
11.
Beyer C E. Depression-like phenotype following chronic CB1 receptor antagonism.
Neurobiology of Disease,2010,39:148-155
|
被引
1
次
|
|
|
|
|
12.
Bhattacharyya S. Opposite effects of Δ-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Neuropsychopharmacology,2010,35:764-774
|
被引
3
次
|
|
|
|
|
13.
Blessing E M. Cannabidiol as a potential treatment for anxiety disorders.
Neurotherapeutics,2015,12:825-836
|
被引
7
次
|
|
|
|
|
14.
Bonn-Miller M O. Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD.
Drug and Alcohol Dependence,2014,136:162-165
|
被引
4
次
|
|
|
|
|
15.
Bonn-Miller M O. Prospective investigation of the impact of cannabis use disorders on posttraumatic stress disorder symptoms among veterans in residential treatment.
Psychological Trauma: Theory, Research, Practice, and Policy,2013,5:193-200
|
被引
1
次
|
|
|
|
|
16.
Butovsky E. Chronic exposure to Δ9-tetrahydrocannabinol downregulates oxytocin and oxytocin-associated neurophysin in specific brain areas.
Molecular and Cellular Neuroscience,2006,31:795-804
|
被引
2
次
|
|
|
|
|
17.
Cabral G A. Endocannabinoids and the immune system in health and disease.
Handbook of Experimental Pharmacology,2015:185-211
|
被引
1
次
|
|
|
|
|
18.
Cameron C. Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: A retrospective evaluation.
Journal of Clinical Psychopharmacology,2014,34:559-564
|
被引
2
次
|
|
|
|
|
19.
Campolongo P. Novelty-induced emotional arousal modulates cannabinoid effects on recognition memory and adrenocortical activity.
Neuropsychopharmacology,2013,38:1276-1286
|
被引
1
次
|
|
|
|
|
20.
Campolongo P. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory.
Proceedings of the National Academy of Sciences of the United States of America,2009,106:4888-4893
|
被引
2
次
|
|
|
|
|
了解气象卫星更多信息，请访问